Cargando…
CCR5 inhibitors: Emerging promising HIV therapeutic strategy
Though potent anti-HIV therapy has spectacularly reduced the morbidity and mortality of human immunodeficiency virus (HIV)-1 infection in the advanced countries, it continues to be associated with substantial toxicity, drug-drug interactions, difficulties in adherence, and abnormal cost. As a result...
Autor principal: | Rao, Padmasri Kutikuppala Surya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168031/ https://www.ncbi.nlm.nih.gov/pubmed/21938106 http://dx.doi.org/10.4103/2589-0557.55471 |
Ejemplares similares
-
Clinical use of CCR5 inhibitors in HIV and beyond
por: Gilliam, Bruce L, et al.
Publicado: (2011) -
Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy
por: Mohamed, Hager, et al.
Publicado: (2022) -
CCR5 Inhibitors and HIV-1 Infection
por: Latinovic, Olga S., et al.
Publicado: (2019) -
CCR5: From Natural Resistance to a New Anti-HIV Strategy
por: Lopalco, Lucia
Publicado: (2010) -
Therapeutic Perspectives of HIV-Associated Chemokine Receptor (CCR5 and CXCR4) Antagonists in Carcinomas
por: González-Arriagada, Wilfredo Alejandro, et al.
Publicado: (2022)